All In Biotech

Drug Trial Radar · NCT07122453

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Single Ascending Doses of Intrathecal CNTX-3001 in Subjects With Intractable Chronic Moderate to Severe Low Back Pain

Last checked: Nov 20, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Mar 2026

Primary completion

Jan 2027

Study completion Jan 2027

Sponsor

Lead sponsor
Centrexion TherapeuticsIndustry
Sponsor type
Industry
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Aug 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical study is being conducted to evaluate the safety, tolerability, plasma pharmacokinetics and efficacy of an investigational drug called CNTX-3001. This Phase 1 study is the first time that CNTX-3001 will be given to people (first-in-human study). The study is being done to evaluate whether CNTX-3001, given into the intrathecal space by lumbar puncture, can be administered safely to participants who have been diagnosed with intractable chronic moderate to severe low back pain and who have not responded well to other treatments in the past. CNTX-3001 is a novel, non-opioid small molecule

Conditions

  • Lower Back Pain

Interventions

  • CNTX-3001Drug

    non-opioid analgesic

  • PlaceboDrug

    Placebo product

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment emergent adverse eventsTime frame: From baseline to the end of treatment visit (Day 7)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neurovations

    Napa, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.